Clinical trials
Lupus Erythematosus, Systemic trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
92 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 8 |
| 2011 | 7 |
| 2012 | 4 |
| 2013 | 5 |
| 2014 | 3 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Active, not recruiting | 17 |
| Recruiting | 14 |
| Terminated | 12 |
| Unknown status | 9 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 7 |
| UCB Pharma | 7 |
| Federal University of São Paulo | 6 |
| Novartis Pharmaceuticals | 6 |
| GlaxoSmithKline | 5 |
| University of Sao Paulo | 5 |
| University of Sao Paulo General Hospital | 5 |
| AstraZeneca | 4 |
| Human Genome Sciences Inc., a GSK Company | 4 |
| MedImmune LLC | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 92 |
| Autoimmune Diseases | 18 |
| Lupus Nephritis | 14 |
| Connective Tissue Diseases | 9 |
| Arthritis, Rheumatoid | 8 |
| Immune System Diseases | 7 |
| Lupus Erythematosus, Cutaneous | 5 |
| Lupus Erythematosus, Discoid | 5 |
| Myositis | 4 |
| Scleroderma, Systemic | 4 |
Trials
Showing 51 to 75 of 92. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.